loading

Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten

Fuel Tech (NASDAQ:FTEK) Earns Hold Rating from Analysts at StockNews.com - Defense World

pulisher
Defense World

NantHealth (NASDAQ:NH) Now Covered by StockNews.com - Defense World

pulisher
Defense World

NantHealth (NASDAQ:NH) Now Covered by StockNews.com - Defense World

pulisher
Defense World

PRA Group (NASDAQ:PRAA) Rating Lowered to Hold at StockNews.com - Defense World

pulisher
Defense World

MIRA Pharmaceuticals, Inc. Expected to Post FY2026 Earnings of ($0.39) Per Share (NASDAQ:MIRA) - Defense World

pulisher
Defense World

Perpetua Resources Corp. (NASDAQ:PPTA) Expected to Earn FY2024 Earnings of ($0.20) Per Share - Defense World

pulisher
Defense World

Confluent, Inc. (NASDAQ:CFLT) Stake Lessened by Amalgamated Bank - Defense World

pulisher
Defense World

Mira Pharmaceuticals reports progress on depression treatment By Investing.com - Investing.com

pulisher
Investing.com

Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace

pulisher
InvestorPlace

MIRA Pharmaceuticals Board Revamp and Strategic Advisory Hire - TipRanks.com - TipRanks

pulisher
TipRanks

Baker Hill Nominated for Tech Company of the Year in TechPoint's 25th Annual Mira Awards - PR Newswire

pulisher
PR Newswire

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

pulisher
InvestorPlace

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.18% - Investing.com India

pulisher
Investing.com India

What's Driving Organon & Co's Surprising 43% Stock Rally? - GuruFocus.com

pulisher
GuruFocus.com

Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

pulisher
Yahoo Finance

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Mo - Benzinga

pulisher
Benzinga

Insiders Could Have Profited By Holding onto MIRA Pharmaceuticals Shares Despite 12% Drop - Simply Wall St

pulisher
Simply Wall St

Biopharma IPO class of 2023 ends the year with performance up 7% - BioWorld Online

pulisher
BioWorld Online

Matthew Perry's ketamine OD prompts questions about its use for mental illness - Bradford Era

pulisher
Bradford Era

Thinking about buying stock in Macy's, Bitfarms, Nio Inc, Li Auto, or Mira Pharmaceuticals? - PR Newswire

pulisher
PR Newswire

Abbott baby formula aftermath: One dead child and another with brain damage so bad she has constant seizures and ... - Fortune

pulisher
Fortune

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid ... - Markets Insider

pulisher
Markets Insider

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid ... - Markets Insider

pulisher
Markets Insider

MIRA, MIRALOGX sign agreement for depression therapy - Pharmaceutical Technology

pulisher
Pharmaceutical Technology

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

What's Going On With Aurinia Pharmaceuticals Stock? - Markets Insider

pulisher
Markets Insider

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India

pulisher
Investing.com India

Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for ... - PR Newswire

pulisher
PR Newswire

Baltimore pharmaceutical company faces delisting from the Nasdaq - Baltimore Business Journal - The Business Journals

pulisher
The Business Journals

Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal - Reuters

pulisher
Reuters

Sanofi weighs Mirati buy as KRAS cancer drug battle enters new phase: Bloomberg - FiercePharma

pulisher
FiercePharma

Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye ... - PR Newswire

pulisher
PR Newswire

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday’ - Benzinga

pulisher
Benzinga

MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time - Barchart

pulisher
Barchart

IPOs take August off - BioCentury

pulisher
BioCentury

Viking to Benefit From Biopharma IPO - Institutional Investor

pulisher
Institutional Investor

Why Shares of Mirati Therapeutics Are Jumping Wednesday - The Motley Fool

pulisher
The Motley Fool

Mira Pharmaceuticals' IPO Fetches $9M, But Filings Spawn More Questions - Green Market Report

pulisher
Green Market Report

MIRA Pharmaceuticals Set to Disrupt Cannabis and Pharma Markets with Nasdaq IPO - mg Magazine

pulisher
mg Magazine

Following the legalization of recreational cannabis, MIRA Pharmaceuticals moves to go public - Technical.ly

pulisher
Technical.ly

Apple acquires Mira, a startup building lightweight AR hardware - TechCrunch

pulisher
TechCrunch

The need for access to anti-TB drugs in India: An interview with Anand Grover - The Leaflet

pulisher
The Leaflet

Johns Hopkins University Researchers Find CBD May Increase the Adverse Effects of THC in Edible Cannabis Products - India Education Diary

pulisher
India Education Diary

CBD May Increase the Adverse Effects of THC in Edible Cannabis Products, Study Shows - Johns Hopkins Medicine

pulisher
Johns Hopkins Medicine
$67.72
price down icon 0.21%
drug_manufacturers_general GSK
$44.98
price up icon 0.22%
drug_manufacturers_general SNY
$48.67
price down icon 0.31%
drug_manufacturers_general PFE
$28.64
price down icon 0.97%
$312.47
price down icon 0.71%
drug_manufacturers_general NVS
$102.57
price down icon 0.12%
Kapitalisierung:     |  Volumen (24h):